Isolation and characterisation of KP34—a novel φKMV-like bacteriophage for Klebsiella pneumoniae

Abstract Bacteriophage KP34 is a novel virus belonging to the subfamily Autographivirinae lytic for extended-spectrum β-lactamase-producing Klebsiella pneumoniae strains. Its biological features, morphology, susceptibility to chemical and physical agents, burst size, host specificity and activity sp...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Drulis-Kawa, Zuzanna [verfasserIn] Mackiewicz, Paweł Kęsik-Szeloch, Agata Maciaszczyk-Dziubinska, Ewa Weber-Dąbrowska, Beata Dorotkiewicz-Jach, Agata Augustyniak, Daria Majkowska-Skrobek, Grażyna Bocer, Tomasz Empel, Joanna Kropinski, Andrew M.

Format:	Artikel
Sprache:	Englisch

Erschienen:	2011

Schlagwörter:	φKMV-like bacteriophage Genome Phage therapy phiKMV-like viruses

Anmerkung:	© The Author(s) 2011

Übergeordnetes Werk:	Enthalten in: Applied microbiology and biotechnology - Springer Berlin Heidelberg, 1984, 90(2011), 4 vom: 16. Feb., Seite 1333-1345
Übergeordnetes Werk:	volume:90 ; year:2011 ; number:4 ; day:16 ; month:02 ; pages:1333-1345

Links:	Volltext

DOI / URN:	10.1007/s00253-011-3149-y

Katalog-ID:	OLC2050735464

Internformat


LEADER	01000caa a22002652 4500
001	OLC2050735464
003	DE-627
005	20230513205515.0
007	tu
008	200820s2011 xx \|\|\|\|\| 00\| \|\|eng c
024	7		\|a 10.1007/s00253-011-3149-y \|2 doi
035			\|a (DE-627)OLC2050735464
035			\|a (DE-He213)s00253-011-3149-y-p
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
082	0	4	\|a 570 \|q VZ
084			\|a 12 \|2 ssgn
084			\|a BIODIV \|q DE-30 \|2 fid
100	1		\|a Drulis-Kawa, Zuzanna \|e verfasserin \|4 aut
245	1	0	\|a Isolation and characterisation of KP34—a novel φKMV-like bacteriophage for Klebsiella pneumoniae
264		1	\|c 2011
336			\|a Text \|b txt \|2 rdacontent
337			\|a ohne Hilfsmittel zu benutzen \|b n \|2 rdamedia
338			\|a Band \|b nc \|2 rdacarrier
500			\|a © The Author(s) 2011
520			\|a Abstract Bacteriophage KP34 is a novel virus belonging to the subfamily Autographivirinae lytic for extended-spectrum β-lactamase-producing Klebsiella pneumoniae strains. Its biological features, morphology, susceptibility to chemical and physical agents, burst size, host specificity and activity spectrum were determined. As a potential antibacterial agent used in therapy, KP34 molecular features including genome sequence and protein composition were examined. Phylogenetic analyses and clustering of KP34 phage genome sequences revealed its clear relationships with “phiKMV-like viruses”. Simultaneously, whole-genome analyses permitted clustering and classification of all phages, with completely sequenced genomes, belonging to the Podoviridae.
650		4	\|a φKMV-like bacteriophage
650		4	\|a Genome
650		4	\|a Phage therapy
650		4	\|a phiKMV-like viruses
700	1		\|a Mackiewicz, Paweł \|4 aut
700	1		\|a Kęsik-Szeloch, Agata \|4 aut
700	1		\|a Maciaszczyk-Dziubinska, Ewa \|4 aut
700	1		\|a Weber-Dąbrowska, Beata \|4 aut
700	1		\|a Dorotkiewicz-Jach, Agata \|4 aut
700	1		\|a Augustyniak, Daria \|4 aut
700	1		\|a Majkowska-Skrobek, Grażyna \|4 aut
700	1		\|a Bocer, Tomasz \|4 aut
700	1		\|a Empel, Joanna \|4 aut
700	1		\|a Kropinski, Andrew M. \|4 aut
773	0	8	\|i Enthalten in \|t Applied microbiology and biotechnology \|d Springer Berlin Heidelberg, 1984 \|g 90(2011), 4 vom: 16. Feb., Seite 1333-1345 \|w (DE-627)129942634 \|w (DE-600)392453-1 \|w (DE-576)015507750 \|x 0175-7598 \|7 nnns
773	1	8	\|g volume:90 \|g year:2011 \|g number:4 \|g day:16 \|g month:02 \|g pages:1333-1345
856	4	1	\|u https://doi.org/10.1007/s00253-011-3149-y \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_OLC
912			\|a FID-BIODIV
912			\|a SSG-OLC-TEC
912			\|a SSG-OLC-CHE
912			\|a SSG-OLC-PHA
912			\|a SSG-OLC-DE-84
912			\|a GBV_ILN_21
912			\|a GBV_ILN_23
912			\|a GBV_ILN_40
912			\|a GBV_ILN_69
912			\|a GBV_ILN_70
912			\|a GBV_ILN_130
912			\|a GBV_ILN_267
912			\|a GBV_ILN_2004
912			\|a GBV_ILN_2018
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4082
912			\|a GBV_ILN_4277
912			\|a GBV_ILN_4305
951			\|a AR
952			\|d 90 \|j 2011 \|e 4 \|b 16 \|c 02 \|h 1333-1345

Indexfelder

author_variant	z d k zdk p m pm a k s aks e m d emd b w d bwd a d j adj d a da g m s gms t b tb j e je a m k am amk
matchkey_str	article:01757598:2011----::sltoadhrceiainfp4nvlmlkbceipae
hierarchy_sort_str	2011
publishDate	2011
allfields	10.1007/s00253-011-3149-y doi (DE-627)OLC2050735464 (DE-He213)s00253-011-3149-y-p DE-627 ger DE-627 rakwb eng 570 VZ 12 ssgn BIODIV DE-30 fid Drulis-Kawa, Zuzanna verfasserin aut Isolation and characterisation of KP34—a novel φKMV-like bacteriophage for Klebsiella pneumoniae 2011 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier © The Author(s) 2011 Abstract Bacteriophage KP34 is a novel virus belonging to the subfamily Autographivirinae lytic for extended-spectrum β-lactamase-producing Klebsiella pneumoniae strains. Its biological features, morphology, susceptibility to chemical and physical agents, burst size, host specificity and activity spectrum were determined. As a potential antibacterial agent used in therapy, KP34 molecular features including genome sequence and protein composition were examined. Phylogenetic analyses and clustering of KP34 phage genome sequences revealed its clear relationships with “phiKMV-like viruses”. Simultaneously, whole-genome analyses permitted clustering and classification of all phages, with completely sequenced genomes, belonging to the Podoviridae. φKMV-like bacteriophage Genome Phage therapy phiKMV-like viruses Mackiewicz, Paweł aut Kęsik-Szeloch, Agata aut Maciaszczyk-Dziubinska, Ewa aut Weber-Dąbrowska, Beata aut Dorotkiewicz-Jach, Agata aut Augustyniak, Daria aut Majkowska-Skrobek, Grażyna aut Bocer, Tomasz aut Empel, Joanna aut Kropinski, Andrew M. aut Enthalten in Applied microbiology and biotechnology Springer Berlin Heidelberg, 1984 90(2011), 4 vom: 16. Feb., Seite 1333-1345 (DE-627)129942634 (DE-600)392453-1 (DE-576)015507750 0175-7598 nnns volume:90 year:2011 number:4 day:16 month:02 pages:1333-1345 https://doi.org/10.1007/s00253-011-3149-y lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_OLC FID-BIODIV SSG-OLC-TEC SSG-OLC-CHE SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_21 GBV_ILN_23 GBV_ILN_40 GBV_ILN_69 GBV_ILN_70 GBV_ILN_130 GBV_ILN_267 GBV_ILN_2004 GBV_ILN_2018 GBV_ILN_4012 GBV_ILN_4082 GBV_ILN_4277 GBV_ILN_4305 AR 90 2011 4 16 02 1333-1345
spelling	10.1007/s00253-011-3149-y doi (DE-627)OLC2050735464 (DE-He213)s00253-011-3149-y-p DE-627 ger DE-627 rakwb eng 570 VZ 12 ssgn BIODIV DE-30 fid Drulis-Kawa, Zuzanna verfasserin aut Isolation and characterisation of KP34—a novel φKMV-like bacteriophage for Klebsiella pneumoniae 2011 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier © The Author(s) 2011 Abstract Bacteriophage KP34 is a novel virus belonging to the subfamily Autographivirinae lytic for extended-spectrum β-lactamase-producing Klebsiella pneumoniae strains. Its biological features, morphology, susceptibility to chemical and physical agents, burst size, host specificity and activity spectrum were determined. As a potential antibacterial agent used in therapy, KP34 molecular features including genome sequence and protein composition were examined. Phylogenetic analyses and clustering of KP34 phage genome sequences revealed its clear relationships with “phiKMV-like viruses”. Simultaneously, whole-genome analyses permitted clustering and classification of all phages, with completely sequenced genomes, belonging to the Podoviridae. φKMV-like bacteriophage Genome Phage therapy phiKMV-like viruses Mackiewicz, Paweł aut Kęsik-Szeloch, Agata aut Maciaszczyk-Dziubinska, Ewa aut Weber-Dąbrowska, Beata aut Dorotkiewicz-Jach, Agata aut Augustyniak, Daria aut Majkowska-Skrobek, Grażyna aut Bocer, Tomasz aut Empel, Joanna aut Kropinski, Andrew M. aut Enthalten in Applied microbiology and biotechnology Springer Berlin Heidelberg, 1984 90(2011), 4 vom: 16. Feb., Seite 1333-1345 (DE-627)129942634 (DE-600)392453-1 (DE-576)015507750 0175-7598 nnns volume:90 year:2011 number:4 day:16 month:02 pages:1333-1345 https://doi.org/10.1007/s00253-011-3149-y lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_OLC FID-BIODIV SSG-OLC-TEC SSG-OLC-CHE SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_21 GBV_ILN_23 GBV_ILN_40 GBV_ILN_69 GBV_ILN_70 GBV_ILN_130 GBV_ILN_267 GBV_ILN_2004 GBV_ILN_2018 GBV_ILN_4012 GBV_ILN_4082 GBV_ILN_4277 GBV_ILN_4305 AR 90 2011 4 16 02 1333-1345
allfields_unstemmed	10.1007/s00253-011-3149-y doi (DE-627)OLC2050735464 (DE-He213)s00253-011-3149-y-p DE-627 ger DE-627 rakwb eng 570 VZ 12 ssgn BIODIV DE-30 fid Drulis-Kawa, Zuzanna verfasserin aut Isolation and characterisation of KP34—a novel φKMV-like bacteriophage for Klebsiella pneumoniae 2011 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier © The Author(s) 2011 Abstract Bacteriophage KP34 is a novel virus belonging to the subfamily Autographivirinae lytic for extended-spectrum β-lactamase-producing Klebsiella pneumoniae strains. Its biological features, morphology, susceptibility to chemical and physical agents, burst size, host specificity and activity spectrum were determined. As a potential antibacterial agent used in therapy, KP34 molecular features including genome sequence and protein composition were examined. Phylogenetic analyses and clustering of KP34 phage genome sequences revealed its clear relationships with “phiKMV-like viruses”. Simultaneously, whole-genome analyses permitted clustering and classification of all phages, with completely sequenced genomes, belonging to the Podoviridae. φKMV-like bacteriophage Genome Phage therapy phiKMV-like viruses Mackiewicz, Paweł aut Kęsik-Szeloch, Agata aut Maciaszczyk-Dziubinska, Ewa aut Weber-Dąbrowska, Beata aut Dorotkiewicz-Jach, Agata aut Augustyniak, Daria aut Majkowska-Skrobek, Grażyna aut Bocer, Tomasz aut Empel, Joanna aut Kropinski, Andrew M. aut Enthalten in Applied microbiology and biotechnology Springer Berlin Heidelberg, 1984 90(2011), 4 vom: 16. Feb., Seite 1333-1345 (DE-627)129942634 (DE-600)392453-1 (DE-576)015507750 0175-7598 nnns volume:90 year:2011 number:4 day:16 month:02 pages:1333-1345 https://doi.org/10.1007/s00253-011-3149-y lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_OLC FID-BIODIV SSG-OLC-TEC SSG-OLC-CHE SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_21 GBV_ILN_23 GBV_ILN_40 GBV_ILN_69 GBV_ILN_70 GBV_ILN_130 GBV_ILN_267 GBV_ILN_2004 GBV_ILN_2018 GBV_ILN_4012 GBV_ILN_4082 GBV_ILN_4277 GBV_ILN_4305 AR 90 2011 4 16 02 1333-1345
allfieldsGer	10.1007/s00253-011-3149-y doi (DE-627)OLC2050735464 (DE-He213)s00253-011-3149-y-p DE-627 ger DE-627 rakwb eng 570 VZ 12 ssgn BIODIV DE-30 fid Drulis-Kawa, Zuzanna verfasserin aut Isolation and characterisation of KP34—a novel φKMV-like bacteriophage for Klebsiella pneumoniae 2011 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier © The Author(s) 2011 Abstract Bacteriophage KP34 is a novel virus belonging to the subfamily Autographivirinae lytic for extended-spectrum β-lactamase-producing Klebsiella pneumoniae strains. Its biological features, morphology, susceptibility to chemical and physical agents, burst size, host specificity and activity spectrum were determined. As a potential antibacterial agent used in therapy, KP34 molecular features including genome sequence and protein composition were examined. Phylogenetic analyses and clustering of KP34 phage genome sequences revealed its clear relationships with “phiKMV-like viruses”. Simultaneously, whole-genome analyses permitted clustering and classification of all phages, with completely sequenced genomes, belonging to the Podoviridae. φKMV-like bacteriophage Genome Phage therapy phiKMV-like viruses Mackiewicz, Paweł aut Kęsik-Szeloch, Agata aut Maciaszczyk-Dziubinska, Ewa aut Weber-Dąbrowska, Beata aut Dorotkiewicz-Jach, Agata aut Augustyniak, Daria aut Majkowska-Skrobek, Grażyna aut Bocer, Tomasz aut Empel, Joanna aut Kropinski, Andrew M. aut Enthalten in Applied microbiology and biotechnology Springer Berlin Heidelberg, 1984 90(2011), 4 vom: 16. Feb., Seite 1333-1345 (DE-627)129942634 (DE-600)392453-1 (DE-576)015507750 0175-7598 nnns volume:90 year:2011 number:4 day:16 month:02 pages:1333-1345 https://doi.org/10.1007/s00253-011-3149-y lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_OLC FID-BIODIV SSG-OLC-TEC SSG-OLC-CHE SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_21 GBV_ILN_23 GBV_ILN_40 GBV_ILN_69 GBV_ILN_70 GBV_ILN_130 GBV_ILN_267 GBV_ILN_2004 GBV_ILN_2018 GBV_ILN_4012 GBV_ILN_4082 GBV_ILN_4277 GBV_ILN_4305 AR 90 2011 4 16 02 1333-1345
allfieldsSound	10.1007/s00253-011-3149-y doi (DE-627)OLC2050735464 (DE-He213)s00253-011-3149-y-p DE-627 ger DE-627 rakwb eng 570 VZ 12 ssgn BIODIV DE-30 fid Drulis-Kawa, Zuzanna verfasserin aut Isolation and characterisation of KP34—a novel φKMV-like bacteriophage for Klebsiella pneumoniae 2011 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier © The Author(s) 2011 Abstract Bacteriophage KP34 is a novel virus belonging to the subfamily Autographivirinae lytic for extended-spectrum β-lactamase-producing Klebsiella pneumoniae strains. Its biological features, morphology, susceptibility to chemical and physical agents, burst size, host specificity and activity spectrum were determined. As a potential antibacterial agent used in therapy, KP34 molecular features including genome sequence and protein composition were examined. Phylogenetic analyses and clustering of KP34 phage genome sequences revealed its clear relationships with “phiKMV-like viruses”. Simultaneously, whole-genome analyses permitted clustering and classification of all phages, with completely sequenced genomes, belonging to the Podoviridae. φKMV-like bacteriophage Genome Phage therapy phiKMV-like viruses Mackiewicz, Paweł aut Kęsik-Szeloch, Agata aut Maciaszczyk-Dziubinska, Ewa aut Weber-Dąbrowska, Beata aut Dorotkiewicz-Jach, Agata aut Augustyniak, Daria aut Majkowska-Skrobek, Grażyna aut Bocer, Tomasz aut Empel, Joanna aut Kropinski, Andrew M. aut Enthalten in Applied microbiology and biotechnology Springer Berlin Heidelberg, 1984 90(2011), 4 vom: 16. Feb., Seite 1333-1345 (DE-627)129942634 (DE-600)392453-1 (DE-576)015507750 0175-7598 nnns volume:90 year:2011 number:4 day:16 month:02 pages:1333-1345 https://doi.org/10.1007/s00253-011-3149-y lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_OLC FID-BIODIV SSG-OLC-TEC SSG-OLC-CHE SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_21 GBV_ILN_23 GBV_ILN_40 GBV_ILN_69 GBV_ILN_70 GBV_ILN_130 GBV_ILN_267 GBV_ILN_2004 GBV_ILN_2018 GBV_ILN_4012 GBV_ILN_4082 GBV_ILN_4277 GBV_ILN_4305 AR 90 2011 4 16 02 1333-1345
language	English
source	Enthalten in Applied microbiology and biotechnology 90(2011), 4 vom: 16. Feb., Seite 1333-1345 volume:90 year:2011 number:4 day:16 month:02 pages:1333-1345
sourceStr	Enthalten in Applied microbiology and biotechnology 90(2011), 4 vom: 16. Feb., Seite 1333-1345 volume:90 year:2011 number:4 day:16 month:02 pages:1333-1345
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	φKMV-like bacteriophage Genome Phage therapy phiKMV-like viruses
dewey-raw	570
isfreeaccess_bool	false
container_title	Applied microbiology and biotechnology
authorswithroles_txt_mv	Drulis-Kawa, Zuzanna @@aut@@ Mackiewicz, Paweł @@aut@@ Kęsik-Szeloch, Agata @@aut@@ Maciaszczyk-Dziubinska, Ewa @@aut@@ Weber-Dąbrowska, Beata @@aut@@ Dorotkiewicz-Jach, Agata @@aut@@ Augustyniak, Daria @@aut@@ Majkowska-Skrobek, Grażyna @@aut@@ Bocer, Tomasz @@aut@@ Empel, Joanna @@aut@@ Kropinski, Andrew M. @@aut@@
publishDateDaySort_date	2011-02-16T00:00:00Z
hierarchy_top_id	129942634
dewey-sort	3570
id	OLC2050735464
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">OLC2050735464</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230513205515.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">200820s2011 xx \|\|\|\|\| 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s00253-011-3149-y</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)OLC2050735464</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-He213)s00253-011-3149-y-p</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">12</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Drulis-Kawa, Zuzanna</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Isolation and characterisation of KP34—a novel φKMV-like bacteriophage for Klebsiella pneumoniae</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2011</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">ohne Hilfsmittel zu benutzen</subfield><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Band</subfield><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© The Author(s) 2011</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Bacteriophage KP34 is a novel virus belonging to the subfamily Autographivirinae lytic for extended-spectrum β-lactamase-producing Klebsiella pneumoniae strains. Its biological features, morphology, susceptibility to chemical and physical agents, burst size, host specificity and activity spectrum were determined. As a potential antibacterial agent used in therapy, KP34 molecular features including genome sequence and protein composition were examined. Phylogenetic analyses and clustering of KP34 phage genome sequences revealed its clear relationships with “phiKMV-like viruses”. Simultaneously, whole-genome analyses permitted clustering and classification of all phages, with completely sequenced genomes, belonging to the Podoviridae.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">φKMV-like bacteriophage</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genome</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Phage therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">phiKMV-like viruses</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mackiewicz, Paweł</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kęsik-Szeloch, Agata</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Maciaszczyk-Dziubinska, Ewa</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Weber-Dąbrowska, Beata</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dorotkiewicz-Jach, Agata</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Augustyniak, Daria</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Majkowska-Skrobek, Grażyna</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bocer, Tomasz</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Empel, Joanna</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kropinski, Andrew M.</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Applied microbiology and biotechnology</subfield><subfield code="d">Springer Berlin Heidelberg, 1984</subfield><subfield code="g">90(2011), 4 vom: 16. Feb., Seite 1333-1345</subfield><subfield code="w">(DE-627)129942634</subfield><subfield code="w">(DE-600)392453-1</subfield><subfield code="w">(DE-576)015507750</subfield><subfield code="x">0175-7598</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:90</subfield><subfield code="g">year:2011</subfield><subfield code="g">number:4</subfield><subfield code="g">day:16</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:1333-1345</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">https://doi.org/10.1007/s00253-011-3149-y</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_OLC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-TEC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-CHE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-DE-84</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_21</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_130</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_267</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2004</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2018</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4082</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4277</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">90</subfield><subfield code="j">2011</subfield><subfield code="e">4</subfield><subfield code="b">16</subfield><subfield code="c">02</subfield><subfield code="h">1333-1345</subfield></datafield></record></collection>
author	Drulis-Kawa, Zuzanna
spellingShingle	Drulis-Kawa, Zuzanna ddc 570 ssgn 12 fid BIODIV misc φKMV-like bacteriophage misc Genome misc Phage therapy misc phiKMV-like viruses Isolation and characterisation of KP34—a novel φKMV-like bacteriophage for Klebsiella pneumoniae
authorStr	Drulis-Kawa, Zuzanna
ppnlink_with_tag_str_mv	@@773@@(DE-627)129942634
format	Article
dewey-ones	570 - Life sciences; biology
delete_txt_mv	keep
author_role	aut aut aut aut aut aut aut aut aut aut aut
collection	OLC
remote_str	false
illustrated	Not Illustrated
issn	0175-7598
topic_title	570 VZ 12 ssgn BIODIV DE-30 fid Isolation and characterisation of KP34—a novel φKMV-like bacteriophage for Klebsiella pneumoniae φKMV-like bacteriophage Genome Phage therapy phiKMV-like viruses
topic	ddc 570 ssgn 12 fid BIODIV misc φKMV-like bacteriophage misc Genome misc Phage therapy misc phiKMV-like viruses
topic_unstemmed	ddc 570 ssgn 12 fid BIODIV misc φKMV-like bacteriophage misc Genome misc Phage therapy misc phiKMV-like viruses
topic_browse	ddc 570 ssgn 12 fid BIODIV misc φKMV-like bacteriophage misc Genome misc Phage therapy misc phiKMV-like viruses
format_facet	Aufsätze Gedruckte Aufsätze
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	nc
hierarchy_parent_title	Applied microbiology and biotechnology
hierarchy_parent_id	129942634
dewey-tens	570 - Life sciences; biology
hierarchy_top_title	Applied microbiology and biotechnology
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)129942634 (DE-600)392453-1 (DE-576)015507750
title	Isolation and characterisation of KP34—a novel φKMV-like bacteriophage for Klebsiella pneumoniae
ctrlnum	(DE-627)OLC2050735464 (DE-He213)s00253-011-3149-y-p
title_full	Isolation and characterisation of KP34—a novel φKMV-like bacteriophage for Klebsiella pneumoniae
author_sort	Drulis-Kawa, Zuzanna
journal	Applied microbiology and biotechnology
journalStr	Applied microbiology and biotechnology
lang_code	eng
isOA_bool	false
dewey-hundreds	500 - Science
recordtype	marc
publishDateSort	2011
contenttype_str_mv	txt
container_start_page	1333
author_browse	Drulis-Kawa, Zuzanna Mackiewicz, Paweł Kęsik-Szeloch, Agata Maciaszczyk-Dziubinska, Ewa Weber-Dąbrowska, Beata Dorotkiewicz-Jach, Agata Augustyniak, Daria Majkowska-Skrobek, Grażyna Bocer, Tomasz Empel, Joanna Kropinski, Andrew M.
container_volume	90
class	570 VZ 12 ssgn BIODIV DE-30 fid
format_se	Aufsätze
author-letter	Drulis-Kawa, Zuzanna
doi_str_mv	10.1007/s00253-011-3149-y
dewey-full	570
title_sort	isolation and characterisation of kp34—a novel φkmv-like bacteriophage for klebsiella pneumoniae
title_auth	Isolation and characterisation of KP34—a novel φKMV-like bacteriophage for Klebsiella pneumoniae
abstract	Abstract Bacteriophage KP34 is a novel virus belonging to the subfamily Autographivirinae lytic for extended-spectrum β-lactamase-producing Klebsiella pneumoniae strains. Its biological features, morphology, susceptibility to chemical and physical agents, burst size, host specificity and activity spectrum were determined. As a potential antibacterial agent used in therapy, KP34 molecular features including genome sequence and protein composition were examined. Phylogenetic analyses and clustering of KP34 phage genome sequences revealed its clear relationships with “phiKMV-like viruses”. Simultaneously, whole-genome analyses permitted clustering and classification of all phages, with completely sequenced genomes, belonging to the Podoviridae. © The Author(s) 2011
abstractGer	Abstract Bacteriophage KP34 is a novel virus belonging to the subfamily Autographivirinae lytic for extended-spectrum β-lactamase-producing Klebsiella pneumoniae strains. Its biological features, morphology, susceptibility to chemical and physical agents, burst size, host specificity and activity spectrum were determined. As a potential antibacterial agent used in therapy, KP34 molecular features including genome sequence and protein composition were examined. Phylogenetic analyses and clustering of KP34 phage genome sequences revealed its clear relationships with “phiKMV-like viruses”. Simultaneously, whole-genome analyses permitted clustering and classification of all phages, with completely sequenced genomes, belonging to the Podoviridae. © The Author(s) 2011
abstract_unstemmed	Abstract Bacteriophage KP34 is a novel virus belonging to the subfamily Autographivirinae lytic for extended-spectrum β-lactamase-producing Klebsiella pneumoniae strains. Its biological features, morphology, susceptibility to chemical and physical agents, burst size, host specificity and activity spectrum were determined. As a potential antibacterial agent used in therapy, KP34 molecular features including genome sequence and protein composition were examined. Phylogenetic analyses and clustering of KP34 phage genome sequences revealed its clear relationships with “phiKMV-like viruses”. Simultaneously, whole-genome analyses permitted clustering and classification of all phages, with completely sequenced genomes, belonging to the Podoviridae. © The Author(s) 2011
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_OLC FID-BIODIV SSG-OLC-TEC SSG-OLC-CHE SSG-OLC-PHA SSG-OLC-DE-84 GBV_ILN_21 GBV_ILN_23 GBV_ILN_40 GBV_ILN_69 GBV_ILN_70 GBV_ILN_130 GBV_ILN_267 GBV_ILN_2004 GBV_ILN_2018 GBV_ILN_4012 GBV_ILN_4082 GBV_ILN_4277 GBV_ILN_4305
container_issue	4
title_short	Isolation and characterisation of KP34—a novel φKMV-like bacteriophage for Klebsiella pneumoniae
url	https://doi.org/10.1007/s00253-011-3149-y
remote_bool	false
author2	Mackiewicz, Paweł Kęsik-Szeloch, Agata Maciaszczyk-Dziubinska, Ewa Weber-Dąbrowska, Beata Dorotkiewicz-Jach, Agata Augustyniak, Daria Majkowska-Skrobek, Grażyna Bocer, Tomasz Empel, Joanna Kropinski, Andrew M.
author2Str	Mackiewicz, Paweł Kęsik-Szeloch, Agata Maciaszczyk-Dziubinska, Ewa Weber-Dąbrowska, Beata Dorotkiewicz-Jach, Agata Augustyniak, Daria Majkowska-Skrobek, Grażyna Bocer, Tomasz Empel, Joanna Kropinski, Andrew M.
ppnlink	129942634
mediatype_str_mv	n
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.1007/s00253-011-3149-y
up_date	2024-07-04T02:43:31.749Z
_version_	1803614695462010880
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">OLC2050735464</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230513205515.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">200820s2011 xx \|\|\|\|\| 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s00253-011-3149-y</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)OLC2050735464</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-He213)s00253-011-3149-y-p</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">12</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Drulis-Kawa, Zuzanna</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Isolation and characterisation of KP34—a novel φKMV-like bacteriophage for Klebsiella pneumoniae</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2011</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">ohne Hilfsmittel zu benutzen</subfield><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Band</subfield><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© The Author(s) 2011</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Bacteriophage KP34 is a novel virus belonging to the subfamily Autographivirinae lytic for extended-spectrum β-lactamase-producing Klebsiella pneumoniae strains. Its biological features, morphology, susceptibility to chemical and physical agents, burst size, host specificity and activity spectrum were determined. As a potential antibacterial agent used in therapy, KP34 molecular features including genome sequence and protein composition were examined. Phylogenetic analyses and clustering of KP34 phage genome sequences revealed its clear relationships with “phiKMV-like viruses”. Simultaneously, whole-genome analyses permitted clustering and classification of all phages, with completely sequenced genomes, belonging to the Podoviridae.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">φKMV-like bacteriophage</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Genome</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Phage therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">phiKMV-like viruses</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mackiewicz, Paweł</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kęsik-Szeloch, Agata</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Maciaszczyk-Dziubinska, Ewa</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Weber-Dąbrowska, Beata</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dorotkiewicz-Jach, Agata</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Augustyniak, Daria</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Majkowska-Skrobek, Grażyna</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bocer, Tomasz</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Empel, Joanna</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kropinski, Andrew M.</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Applied microbiology and biotechnology</subfield><subfield code="d">Springer Berlin Heidelberg, 1984</subfield><subfield code="g">90(2011), 4 vom: 16. Feb., Seite 1333-1345</subfield><subfield code="w">(DE-627)129942634</subfield><subfield code="w">(DE-600)392453-1</subfield><subfield code="w">(DE-576)015507750</subfield><subfield code="x">0175-7598</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:90</subfield><subfield code="g">year:2011</subfield><subfield code="g">number:4</subfield><subfield code="g">day:16</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:1333-1345</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">https://doi.org/10.1007/s00253-011-3149-y</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_OLC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-TEC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-CHE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-DE-84</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_21</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_130</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_267</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2004</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2018</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4082</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4277</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">90</subfield><subfield code="j">2011</subfield><subfield code="e">4</subfield><subfield code="b">16</subfield><subfield code="c">02</subfield><subfield code="h">1333-1345</subfield></datafield></record></collection>
score	7.400056

Nicht das Richtige dabei?

Schreiben Sie uns!

Isolation and characterisation of KP34—a novel φKMV-like bacteriophage for Klebsiella pneumoniae

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?